COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 570: Articles 5691-5700  | Next

Causal Inference of CNS-regulated Hormones in COVID-19: A Bidirectional Two-sample Mendelian Randomization Study
Sun, Y., Ding, Z., Guo, Y., Yuan, J., Zhu, C., Pan, Y., Sun, R.
10.1101/2022.12.07.22283193 — Posted: 2022-12-07
Physical and mental health disability associated with long-COVID: Baseline results from a US nationwide cohort.
Lau, B., Wentz, E., Ni, Z., Yenokyan, K., Coggiano, C., Mehta, S. H., Duggal, P.
10.1101/2022.12.07.22283203 — Posted: 2022-12-07
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial.
Toshner, M. R., Gamble, C., Baillie, J. K., Best, A., Bedson, E., Bradley, J., Calvert, M., Davies, E. H., Docherty, A. B., Gkioni, E., Hughes, D. A., Jaki, T., Jenkins, R. G., Jones, A., Landray, M. J., Mant, J., McAuley, D. F., Openshaw, P. J., Richards, D., Wicks, P., HEAL-COVID Collaboration, , Summers, C.
10.1101/2022.12.07.22283175 — Posted: 2022-12-07
Mapping disease regulatory circuits at cell-type resolution from single-cell multiomics data
Chen, X., Wang, Y., Cappuccio, A., Cheng, W.-S., Ruf-Zamojski, F., Nair, V., Miller, C. M., Rubenstein, A., Nudelman, G., Tadych, A., Theesfield, C., Vornholt, A., George, M.-C., Ruffin, F., Dagher, M., Chawla, D., Soares-Schanoski, A., Spurbeck, R. R., Ndhlovu, L. C., Sebra, R., Kleinstein, S., Letizia, A. G., Ramos-lopez, I., Fowler, V. G., Woods, C. W., Zaslavsky, E., Troyanskaya, O. G., Sealfon, S. C.
10.1101/2022.12.06.22282077 — Posted: 2022-12-07
Non-generalizability of biomarkers for mortality in SARS-CoV-2: a meta-analyses series
Shuvo, M. R., Schweining, M., Soares, F., Feng, O., Abreu, S., Veale, N., Thomas, W., Thompson, A. R., Samworth, R., Morrell, N. W., Marciniak, S., Soon, E.
10.1101/2022.12.03.22282974 — Posted: 2022-12-07
Emergence and antibody evasion of BQ and BA.2.75 SARS-CoV-2 sublineages in the face of maturing antibody breadth at the population level
Akerman, A., Milogiannakis, V., Jean, T., Esneu, C., Ruiz Silva, M., Ison, T., Fichter, C., Chandra, D., Naing, Z., Walker, G., Caguicla, J., Li, d., Amatayakul-Chantler, S., Manni, S., Roth, N., Hauser, T., Condylios, A., Yeang, M., Wong, M., Foster, C. S. P., Lee, S., Song, Y., Mao, L., Phu, A., Sigmund, A., Van de More, A. M., Hunt, S., Sandgren, K., Bull, R., Lloyd, A., Triccas, J., Tangye, S., Cunningham, A. L., Bartlett, N. W., Darley, D., Matthews, G., Douglas, M., Caterson, I., Rawlinson, W. D., Brilot, F., Stark, D. J., Kelleher, A. D., Aggarwal, A., Turville, S. G.
10.1101/2022.12.06.22283000 — Posted: 2022-12-07
Lack of effectiveness of Bebtelovimab Monoclonal Antibody Among High-Risk Patients with SARS-Cov-2 Omicron During BA.2, BA.2.12.1 and BA.5 Subvariants Dominated Era
Sridhara, S., Gungor, A. B., Erol, H. K., Al-Obaidi, M., Zangeneh, T., Bedrick, E., Ariyamuthu, V., Shetty, A., Qannus, A. A., Mendoza, K., Murugapandian, S., Gupta, G., Tanriover, B.
10.1101/2022.12.06.22283183 — Posted: 2022-12-07
Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome
Paniskaki, K., Konik, M., Anft, M., Heidecke, H., Meister, T., Pfaender, S., Krawczyk, A., Zettler, M., Jäger, J., Gaeckler, A., Dolff, S., Westhoff, T., Rohn, H., Stervbo, U., Scheibenbogen, C., Witzke, O., Babel, N.
10.1101/2022.12.03.519007 — Posted: 2022-12-07
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
Dayan, G. H., Rouphael, N., Walsh, S. R., Chen, A., Grunenberg, N., Allen, M., Antony, J., Asante, K. P., Suresh Bhate, A., Beresnev, T., Bonaparte, M. I., Angeles Ceregido, M., Dobrianskyi, D., Fu, B., Grillet, M.-H., Keshtkar-Jahromi, M., Juraska, M., Jin Kee, J., Kibuuka, H., Koutsoukos, M., Masotti, R., Michael, N. L., Reynales, H., Robb, M. L., Villagomez Martinez, S. M., Sawe, F., Schuerman, L., Tong, T., Treanor, J., Wartel, T. A., Diazgranados, C. A., Chicz, R. M., Gurunathan, S., Savarino, S., Sridhar, S., the VAT00008 study team
10.1101/2022.12.05.22282933 — Posted: 2022-12-06
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
Bajema, K. L., Berry, K., Streja, E., Rajeevan, N., Li, Y., Yan, L., Cunningham, F., Hynes, D. M., Rowneki, M., Bohnert, A., Boyko, E. J., Iwashyna, T. J., Maciejewski, M. L., Osborne, T. F., Viglianti, E. M., Aslan, M., Huang, G. D., Ioannou, G. N.
10.1101/2022.12.05.22283134 — Posted: 2022-12-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).